Edition:
United States

John Miller

Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.

Twitter handle: @jeffmason1

Jul 19 2017

Poor test results for Roche cloud growth prospects

ZURICH A run of disappointing drug trials at Roche has left analysts suggesting the view from its new 41-storey office building in Basel has become more clouded, with little chance of management now upgrading its growth forecast next week, when it reports first-half earnings.

Jul 14 2017

Sports court cuts World Cup inspector's soccer ban to two years

ZURICH A Swiss-based court reduced a ban on Friday on a FIFA official who checked part of Qatar's bid to host the 2022 World Cup, clearing the way for his return to soccer this month.

Jul 14 2017

Novartis stocks drug cabinet with "Big-3" arthritis blockbusters

ZURICH Switzerland's Novartis is stocking up cheaper versions of the world's top-selling arthritis medicines, hoping a broad portfolio gives it an edge on rivals with narrower offerings.

Jul 12 2017

Swiss Landis+Gyr eager to exit Toshiba's cloud with $2.5 billion listing

ZURICH Swiss firm Landis+Gyr, Toshiba's smart meters business, reckons it will be valued at up to 2.4 billion Swiss francs ($2.5 billion) in its upcoming share listing and is keen to cut ties with its scandal-hit parent.

Jul 11 2017

Novartis readies for FDA review of $1 billion CAR-T child cancer hope

ZURICH Two decades ago in a Memphis, Tenn., hospital lab, cancer scientist Dario Campana and his team were hunting for a new way to fight deadly acute lymphoblastic leukemia (ALL).

Jul 10 2017

Shire, Roche slug it out in billion-dollar haemophilia drug battle

ZURICH Swiss drugmaker Roche's bid to take a chunk of the $11 billion haemophilia drug market dominated by Shire took another blow with the Irish company winning a preliminary injunction over its Swiss rival's medication.

Jul 07 2017

Swiss museum readies for Nazi-era art trove show, seeks works' heirs

BERN A Swiss museum director preparing for a Nazi-era art collection's long-awaited public unveiling later this year said Friday that her goal remains finding heirs to any works that may have been looted from Jewish owners.

Jul 04 2017

Corvex, NYC investment group seek to scuttle Clariant-Huntsman deal

ZURICH Activist investor Keith Meister's Corvex hedge fund and New York's 40 North have taken a 7.2 percent stake in Clariant to fight the Swiss chemical maker's planned merger with Huntsman Corp .

Jul 03 2017

Smart meter maker Landis+Gyr plans IPO, sale still an option

ZURICH Swiss smart meter maker Landis+Gyr plans an initial public offering (IPO) in the third quarter as its owner, Japanese conglomerate Toshiba, scrambles to raise funds to cover losses at bankrupt U.S. nuclear unit Westinghouse.

Jun 30 2017

Roche buys diabetes app firm in digital health push

ZURICH Roche has bought Vienna-based diabetes management platform mySugr for an undisclosed price, the Swiss drugmaker said on Friday, joining a crowd of companies expanding app-based digital health services.

Markets

  • U.S.
  • Europe
  • Asia
  • Sectors

Sector Summary